In this interview, Anders Björklund speaks to us about how we might overcome the current limitations of using stem cell therapies for Parkinson’s disease.
Browsing: Cognitive/neurodegenerative disorders
Long-term antibiotic treatment may reduce the size of amyloid plaques and could alter the appearance of microglia in the brains of male mice.
In this interview, we spoke with Viviane Labrie about her research into the vermiform appendix as a possible contributor to Parkinson’s disease.
New guidelines from the World Health Organization recommend specific interventions for reducing the risk of dementia and cognitive decline.
In a study focused on a group of former professional athletes who have experienced multiple concussions, over half the group were reported to have higher levels of tau protein biomarkers in their cerebrospinal fluid.
Researchers have developed FRW, a peptide that can bind to blood vessels without binding to other organs; this could lead to novel imaging techniques for neurodegenerative diseases.
A recent clinical trial has demonstrated that the drug, IONIS-HTTRx, is safe for use in people with Huntington’s disease.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
A preliminary clinical study has demonstrated that the experimental drug tofersen may be effective in the treatment of a genetic form of ALS.